Paul McBarron
2009
In 2009, Paul McBarron earned a total compensation of $392.7K as Executive Vice President, Finance, Chief Operating Officer, Chief Financial Officer, and Secretary at Cyclacel Pharmaceuticals.
Compensation breakdown
| Bonus | $86,489 |
|---|---|
| Salary | $288,297 |
| Other | $17,903 |
| Total | $392,689 |
McBarron received $288.3K in salary, accounting for 73% of the total pay in 2009.
McBarron also received $86.5K in bonus and $17.9K in other compensation.
Rankings
In 2009, Paul McBarron's compensation ranked 7,616th out of 9,885 executives tracked by ExecPay. In other words, McBarron earned more than 23.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,616 out of 9,885 | 23rd |
Division Manufacturing | 2,843 out of 3,690 | 23rd |
Major group Chemicals And Allied Products | 643 out of 866 | 26th |
Industry group Drugs | 459 out of 638 | 28th |
Industry Pharmaceutical Preparations | 340 out of 446 | 24th |
Source: SEC filing on April 26, 2011.
McBarron's colleagues
We found two more compensation records of executives who worked with Paul McBarron at Cyclacel Pharmaceuticals in 2009.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020